Weighted Average Number of Shares Outstanding, Basic of Silence Therapeutics plc from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Silence Therapeutics plc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • Silence Therapeutics plc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 141,694,702, a 2.1% increase year-over-year.
  • Silence Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 141,694,702, a 2.1% increase from 2024.
  • Silence Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 138,752,224, a 25% increase from 2023.
  • Silence Therapeutics plc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 111,277,250, a 15% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Silence Therapeutics plc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 141,694,702 +2,942,478 +2.1% 01 Oct 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 141,701,848 +503,685 +0.36% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 141,696,047 +1,487,118 +1.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 141,678,734 +9,797,619 +7.4% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 138,752,224 01 Oct 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 141,198,163 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 140,208,929 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 131,881,115 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1

Silence Therapeutics plc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 141,694,702 +2,942,478 +2.1% 01 Jan 2025 31 Dec 2025 10-K 05 Mar 2026 2025 FY
2024 138,752,224 +27,474,974 +25% 01 Jan 2024 31 Dec 2024 10-K 05 Mar 2026 2025 FY
2023 111,277,250 +14,692,738 +15% 01 Jan 2023 31 Dec 2023 10-K 27 Feb 2025 2024 FY
2022 96,584,512 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.